The Relationship Between HbA1c Levels and Severity of COVID-19 Patients with Diabetes Mellitus at Haji General Hospital, East Java Province
Abstract
One of the factors influencing SARS-CoV-2 infection is comorbidity. Diabetes mellitus is a comorbidity with a high mortality rate. Poor glucose control in patients can affect cellular immune responses and increase morbidity and mortality associated with infections. The severity of COVID-19 is classified into 5 levels: asymptomatic, mild, moderate, severe, and critical. HbA1c is a good test for identifying the diabetes status of COVID-19 patients. According to the American Diabetes Association, HbA1c levels are considered controlled if <7% and uncontrolled if ≥7%. This study aims to analyze HbA1c levels in COVID-19 patients with diabetes mellitus from 2020 to 2022. This study uses the productive age category (15-64 years). To determine the relationship between HbA1c levels and the severity of COVID-19 patients with diabetes mellitus at Haji General Hospital, East Java Province, from 2020 to 2022. This research employs a cross-sectional, analytical observational method with a consecutive sampling technique involving 96 hospitalized COVID-19 patients. Data collection was conducted through medical record observation. The majority of the samples were male, with an average age of 53 years. The Fisher Exact Test yielded a p-value of 0.13, which is greater than the significance level (0.05), indicating no significant relationship between HbA1c levels and the severity of COVID-19 in diabetic patients. There is no significant relationship between HbA1c levels and the severity of COVID-19 in diabetic patients at Haji General Hospital, East Java Province.
References
Bangsa, M. T. S., & Setyawati, T. (2022). COVID-19 Variances and Mutations. Journal of Medical Profession, 4(2), 201.
Burhan, E., Susanto, A. D., Nasution, S. A., Eka, G., Pitoyo, C., Susilo, A., Firdaus, I., Santoso, A., Juzar, D. A., & Arif, S. K. (2022). Myocardial injury in COVID-19 infection. In Guidelines for the Management of COVID-19, 4th edition.
Cariou, B., Hadjadj, S., Wargny, M., Pichelin, M., & Al-salameh, A. (2021). Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. 2020, 1500–1515.
Cheng, Y., Yue, L., Wang, Z., Zhang, J., & Xiang, G. (2020). Since January 2020, Elsevier has created a COVID-19 resource center with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource center is hosted on Elsevier Connect, the company’s public news and information platform. January.
Patel, A. J., Klek, S. P., Peragallo-Dittko, V., Goldstein, M., Burdge, E., Nadile, V., Ramadhar, J., Islam, S., & Gary, D. (2020).
Praptika, N. L. P., & Karya, K. W. S. (2021). The Role of HbA1c in the Progression and Prognosis of COVID-19 in Diabetes Mellitus Patients. Intisari Sains Medis, 12(3), 682–688. https://doi.org/10.15562/ism.v12i3.1113
Sardu, C., D’Onofrio, N., Balestrieri, M. L., Barbieri, M., Rizzo, M. R., Messina, V., Maggi, P., Coppola, N., Paolisso, G., & Marfella, R. (2020). Hyperglycemia on Admission to Hospital and COVID-19. Diabetologia, 63(11), 2486–2487. https://doi.org/10.1007/s00125-020-05216-2
Song, F., Shi, N., Shan, F., Zhang, Z., Shen, J., Lu, H., Ling, Y., Jiang, Y., & Shi, Y. (2020). Emerging 2019 Novel Coronavirus (2019-NCoV) Pneumonia. Radiology, 295(1), 210–217. https://doi.org/10.1148/radiol.2020200274
Team, C.-F. (2022). Variation in the COVID-19 Infection–Fatality Ratio by Age, Time, and Geography During the Pre-Vaccine Era: A Systematic Analysis. The Lancet, 399(10334), 1469–1488. https://doi.org/10.1016/S0140-6736(21)02867-1
Wang, B., Glicksberg, B. S., Nadkarni, G. N., & Vashishth, D. (2021). Evaluation and Management of COVID-19-Related Severity in People with Type 2 Diabetes. BMJ Open Diabetes Research and Care, 9(1), 1–9. https://doi.org/10.1136/bmjdrc-2021-002299
Zhou, Y., Chi, J., Lv, W., & Wang, Y. (2021). Obesity and Diabetes as High-Risk Factors for Severe Coronavirus Disease 2019 (COVID-19). Diabetes/Metabolism Research and Reviews, 37(2). https://doi.org/10.1002/dmrr.3377
Zhu, Z., Mao, Y., & Chen, G. (2021). Predictive Value of HbA1c for In-Hospital Adverse Prognosis in COVID-19: A Systematic Review and Meta-Analysis. Primary Care Diabetes, 15(6), 910–917. https://doi.org/10.1016/j.pcd.2021.07.013
Authors
Copyright (c) 2024 Nabil Salim Ambar, Muhimmatul Aaliyah Rahmadina, Mohammad Subkhan, Audy Meutia Ariana
This work is licensed under a Creative Commons Attribution 4.0 International License.
Qanun Medika by FK UM Surabaya is liscence under Lisensi Creative Commons Atribusi 4.0 Internasional.
